Literature DB >> 17696708

Axis I and II comorbidity in adults with ADHD.

Torri W Miller1, Joel T Nigg, Stephen V Faraone.   

Abstract

Ongoing debate over the validity of the attention-deficit/hyperactivity disorder (ADHD) construct in adulthood is fueled in part by uncertainty regarding implications of potentially extensive yet incompletely described comorbid Axis I and II psychopathology. Three hundred sixty-three adults ages 18 to 37 completed semistructured clinical interviews; informants were also interviewed, and best estimate diagnoses were obtained. Results were as follows: First, ADHD combined type (ADHD-C) had an excess of externalizing and internalizing Axis I disorders, suggesting a gradient-of-severity relationship between it and ADHD inattentive type (ADHD-I). Second, ADHD-C and ADHD-I did not differ in frequency of Axis II disorders. Third, however, ADHD overall was associated with increased rates of Axis II disorders, compared with rates in non-ADHD control participants, including both Cluster B (primarily borderline personality disorder) and Cluster C disorders. Fourth, ADHD incrementally accounted for clinician-rated global assessment of functioning scores above and beyond comorbid conditions or symptoms on either Axis I or Axis II. Results further inform nosology of ADHD in adults. (c) 2007 APA, all rights reserved

Entities:  

Mesh:

Year:  2007        PMID: 17696708     DOI: 10.1037/0021-843X.116.3.519

Source DB:  PubMed          Journal:  J Abnorm Psychol        ISSN: 0021-843X


  31 in total

Review 1.  An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults.

Authors:  Timothy E Wilens; Nicholas R Morrison; Jefferson Prince
Journal:  Expert Rev Neurother       Date:  2011-10       Impact factor: 4.618

2.  Atypical default network connectivity in youth with attention-deficit/hyperactivity disorder.

Authors:  Damien A Fair; Jonathan Posner; Bonnie J Nagel; Deepti Bathula; Taciana G Costa Dias; Kathryn L Mills; Michael S Blythe; Aishat Giwa; Colleen F Schmitt; Joel T Nigg
Journal:  Biol Psychiatry       Date:  2010-08-21       Impact factor: 13.382

3.  Potential contribution of monoamine oxidase a gene variants in ADHD and behavioral co-morbidities: scenario in eastern Indian probands.

Authors:  A Karmakar; S Maitra; D Verma; B Chakraborti; R Goswami; P Ghosh; S Sinha; K P Mohanakumar; R Usha; K Mukhopadhyay
Journal:  Neurochem Res       Date:  2014-03-21       Impact factor: 3.996

4.  Adolescents with childhood ADHD and comorbid disruptive behavior disorders: aggression, anger, and hostility.

Authors:  Seth C Harty; Carlin J Miller; Jeffrey H Newcorn; Jeffrey M Halperin
Journal:  Child Psychiatry Hum Dev       Date:  2008-07-03

5.  Attention deficit/hyperactivity disorder in female offenders: prevalence, psychiatric comorbidity and psychosocial implications.

Authors:  Michael Rösler; Wolfgang Retz; Khalid Yaqoobi; Eva Burg; Petra Retz-Junginger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-09-19       Impact factor: 5.270

6.  Developmental differences in structure of attention-deficit/hyperactivity disorder (ADHD) between childhood and adulthood.

Authors:  Michelle M Martel; Alexander von Eye; Joel Nigg
Journal:  Int J Behav Dev       Date:  2012-07

Review 7.  Current status of cognitive behavioral therapy for adult attention-deficit hyperactivity disorder.

Authors:  Laura E Knouse; Steven A Safren
Journal:  Psychiatr Clin North Am       Date:  2010-09

8.  Differences at brain SPECT between depressed females with and without adult ADHD and healthy controls: etiological considerations.

Authors:  Ann Gardner; Dario Salmaso; Andrea Varrone; Alejandro Sanchez-Crespo; Susanne Bejerot; Hans Jacobsson; Stig A Larsson; Marco Pagani
Journal:  Behav Brain Funct       Date:  2009-09-01       Impact factor: 3.759

9.  Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD).

Authors:  Sören Schmidt; Franz Petermann
Journal:  BMC Psychiatry       Date:  2009-09-17       Impact factor: 3.630

10.  Screening for personality disorder with the Standardised Assessment of Personality: Abbreviated Scale (SAPAS): further evidence of concurrent validity.

Authors:  Morten Hesse; Paul Moran
Journal:  BMC Psychiatry       Date:  2010-01-28       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.